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The Ethics Committee as Ghost Author 
 
  Ethics committees have a bad reputation for impeding, rather than facilitating research. 
Tales abound of delays and rejections of perfectly innocuous studies. Here, I argue that 
many committees actually improve the quality of the research proposal to such an extent 
that they deserve credit as authors in any resulting publications, or at least an 
acknowledgement of the contribution made. 
 
  One of the reasons that applicants are often angry at ECs is that they question the 
science of the proposal. Many researchers believe that this is not the role of the EC, and 
indeed the recently revised GAFREC document states that: 
 
A REC need not reconsider the quality of the science, as this is the responsibility 
of the sponsor and will have been subject to review by one or more experts in the 
field (known as ‘peer review’). The REC will be satisfied with credible assurances 
that the research has an identified sponsor and that it takes account of 
appropriate scientific peer review.[1] 
 
 However, in many cases this advice simply cannot be followed. The job of an ethics 
committee is to protect participants, and exposing patients to potential harm for the 
sake of a study that simply cannot answer its own research question is deeply 
unethical. It might be argued that ECs should not intervene where there is no risk of 
harm, but the research question cannot be answered; I believe that wasting people's 
time and making them think they're contributing to research is not to fully respect 
them or safeguard their rights. In any case, an EC would look rather stupid if it gave a 
favourable opinion to a study with serious scientific flaws, and it is difficult to see how 
a REC would be “satisfied with assurances” when there are obvious flaws in the 
design.  
 
 Equally, however, ECs tend not to simply reject such studies outright; rather, they 
offer constructive criticism and often suggest ways to improve recruitment, statistics 
and trial design. This can lead to some delay, but the result is frequently approval of a 
study that is a significant improvement on what was originally submitted.  In one 
recent study I reviewed, the research in question was intended to provide evidence 
that a particular intervention worked; had we approved it as it was originally 
submitted, we would have wasted the participants' time and the results might have 
been used to justify the use of public funds for such an intervention when the 
evidence was deeply flawed. Instead, we suggested major revisions to the design 
which were implemented. In such cases, the committee has made a substantial 
contribution towards the design of the study; if a colleague of the principal 
investigator were to make such a contribution, and her name was not included when 
the results were published, she would have been treated badly. The phenomenon of 
ghost authorship is ongoing despite widespread condemnation; why should the input 
of ethics committees be treated any differently?  
 
 At present the only credit ethics committees receive is the statement that “this 
research was approved by XXXX” in small type on the published paper. I would 
suggest that the ethics committee should be listed as an author in cases where they 
have significantly improved the design of the study. This might be embarrassing for 
the main authors, but credit should be attributed where it is due, and this would not 
be necessary if the original proposal had really undergone proper scientific review or 
been designed properly in the first place. Given that authorship is frequently 
attributed to people who have had only marginal involvement in the design of the 
study, it does not appear unreasonable to give credit to the EC. At the very least, an 
acknowledgement should be made of the input of the ethics committee, even if it is 
not listed as an author.  
 
  My recommendation is based on current practice in authorship in many universities 
and companies. However, if we wish to adhere to the highest standards (which many 
are not doing yet), it would appear that ethics committees would not qualify as true 
authors. The ICJME states that: 
 
authorship credit should be based on 1) substantial contributions to conception and 
design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or 
revising it critically for important intellectual content; and 3) final approval of the version to 
be published. Authors should meet conditions 1, 2, and 3. [2] 
 
  The ethics committee clearly meets the first of these criteria in some cases, but will not 
meet the second or third. But how many people who have been listed as authors can truly 
say that they have met all three criteria? Furthermore, the same guidelines state that  
contributors who do not meet the above criteria should be mentioned in the 
acknowledgement section: “editors should ask corresponding authors to declare whether 
they had assistance with study design...If such assistance was available, the authors 
should disclose the identity of the individuals who provided this assistance and the entity 
that supported it in the published article.”  
 
Therefore, ethics committees (in the UK) and IRBs (in the USA) should either have full 
authorship attribution (going by current standards) or at the very least an 
acknowledgement (going by the highest standard). The ICMJE suggests acknowledgment 
of “scientific advisers” and those who “critically reviewed the study proposal”; the latter is 
probably the most appropriate. An example acknowledgement would be “Thanks to NHS 
West of Scotland Research Ethics Committee 2, who critically reviewed this proposal and 
suggested improvements to the design.” Once again, though, there must be many 
academics who have done just this and been listed as a full author. Ironically, ethics 
committees are currently being treated unethically by researchers who deny them credit for 
their input. 
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